NASDAQ:NUTX Nutex Health (NUTX) Stock Forecast, Price & News $0.21 0.00 (0.00%) (As of 10/2/2023 ET) Add Compare Share Share Today's Range$0.20▼$0.2150-Day Range$0.19▼$0.4252-Week Range$0.18▼$2.46Volume748,939 shsAverage Volume2.02 million shsMarket Capitalization$137.21 millionP/E RatioN/ADividend YieldN/APrice Target$2.75 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Nutex Health MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,226.6% Upside$2.75 Price TargetShort InterestHealthy0.72% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.62Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.03) to ($0.02) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.11 out of 5 starsMedical Sector514th out of 975 stocksBusiness Services, Not Elsewhere Classified Industry62nd out of 89 stocks 3.5 Analyst's Opinion Consensus RatingNutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.75, Nutex Health has a forecasted upside of 1,226.6% from its current price of $0.21.Amount of Analyst CoverageNutex Health has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.72% of the float of Nutex Health has been sold short.Short Interest Ratio / Days to CoverNutex Health has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutex Health has recently increased by 114.04%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldNutex Health does not currently pay a dividend.Dividend GrowthNutex Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NUTX. Previous Next 2.6 News and Social Media Coverage News SentimentNutex Health has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Nutex Health this week, compared to 1 article on an average week.Search InterestOnly 4 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.MarketBeat Follows2 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nutex Health insiders have not sold or bought any company stock.Percentage Held by Insiders48.48% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.79% of the stock of Nutex Health is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Nutex Health are expected to grow in the coming year, from ($0.03) to ($0.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nutex Health is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nutex Health is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNutex Health has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Nutex Health (NASDAQ:NUTX) StockNutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.Read More NUTX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUTX Stock News HeadlinesSeptember 20, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES PARTICIPATION IN THE 2023 CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCESeptember 13, 2023 | thestreet.comNutex Health Inc.October 3, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.September 9, 2023 | finance.yahoo.comChairman of the Board & CEO of Nutex Health Thomas Vo Buys More StockSeptember 7, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCESSeptember 5, 2023 | bizjournals.comMicrohospital operator Nutex Health hires new COOSeptember 5, 2023 | msn.comNutex Health gets new operations chiefSeptember 5, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JOSHUA DETILLIO AS ITS NEW CHIEF OPERATING OFFICEROctober 3, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.September 2, 2023 | finance.yahoo.comInsider Buying: CEO Thomas Vo Acquires 1,000,000 Shares of Nutex Health Inc (NUTX)August 22, 2023 | markets.businessinsider.comNutex Health Acquires PHA & MCIC To Boost Presence In FloridaAugust 12, 2023 | finance.yahoo.comUS$2.75: That's What Analysts Think Nutex Health Inc. (NASDAQ:NUTX) Is Worth After Its Latest ResultsAugust 11, 2023 | finance.yahoo.comInsiders of Nutex Health Inc. (NASDAQ:NUTX) must be disappointed as stock fell 17% after recent purchasesAugust 10, 2023 | finanznachrichten.deNutex Health, Inc.: Nutex Health Reports Second Quarter 2023 Financial ResultsAugust 9, 2023 | finance.yahoo.comNutex Health Inc. (NUTX) Reports Q2 Loss, Lags Revenue EstimatesAugust 9, 2023 | finance.yahoo.comNUTEX HEALTH REPORTS SECOND QUARTER 2023 FINANCIAL RESULTSAugust 7, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES THE OPENING OF A NEW HOSPITAL IN TEXAS, BRINGING THE FIRST HOSPITAL AND MRI TO ROYSE CITYJuly 31, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES THAT ITS ADVANCED POPULATION HEALTH ANALYTICS PLATFORM HAS BEEN SELECTED BY VARMED MANAGEMENT TO ENHANCE PATIENT CAREJuly 18, 2023 | finance.yahoo.comNUTEX HEALTH HOSPITALS WIN SIX NEW OUTSTANDING AWARDSJuly 5, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES THE OPENING OF A NEW HOSPITAL IN LOUISIANAJune 27, 2023 | bizjournals.comNutex Health opens second micro-hospital in Northeast AlbuquerqueJune 21, 2023 | msn.comWhy Shares of Nutex Health Jumped on WednesdayJune 20, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES THE OPENING OF A NEW HOSPITAL IN ALBUQUERQUE, NEW MEXICOJune 5, 2023 | finance.yahoo.comNUTEX HEALTH TO PRESENT AT THE STIFEL 2023 CROSS SECTOR INSIGHT CONFERENCE ON JUNE 7 IN BOSTONMay 30, 2023 | benzinga.com523K Reasons To Be Bullish On Nutex Health StockMay 25, 2023 | tmcnet.comMeMed: Nutex Health Announces Agreement with MeMed to Adopt Pioneering MeMed BV® Test Across its Network of 19 sitesMay 19, 2023 | msn.comWhy Shares of Nutex Health Jumped on FridaySee More Headlines Receive NUTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter. Email Address NUTX Company Calendar Last Earnings8/09/2023Today10/02/2023Next Earnings (Estimated)11/20/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NUTX CUSIPN/A CIK1479681 Webwww.nutexhealth.com Phone(713) 660-0557Fax631-670-6780Employees1,150Year FoundedN/APrice Target and Rating Average Stock Price Forecast$2.75 High Stock Price Forecast$3.00 Low Stock Price Forecast$2.50 Forecasted Upside/Downside+1,226.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-424,780,000.00 Net Margins-225.91% Pretax Margin-229.63% Return on Equity-31.81% Return on Assets-8.64% Debt Debt-to-Equity Ratio2.27 Current Ratio1.60 Quick Ratio1.56 Sales & Book Value Annual Sales$219.29 million Price / Sales0.63 Cash FlowN/A Price / Cash FlowN/A Book Value$0.19 per share Price / Book1.09Miscellaneous Outstanding Shares661,900,000Free Float341,010,000Market Cap$137.21 million OptionableNot Optionable Beta0.77 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Thomas T. Vo M.B.A. (Age 50)M.D., Chairman & CEO Comp: $938.23kDr. Warren Hosseinion M.D. (Age 51)Pres & Director Comp: $937.66kMr. Jon C. Bates CPA (Age 52)M.B.A., Chief Financial Officer Comp: $299.46kMr. Michael C. Bowen (Age 78)Exec. Officer Comp: $460.2kMs. Pamela W. Montgomery B.S.N. (Age 57)J.D., L.L.M., M.S.N., R.N., Chief Legal Officer of Healthcare & Board Sec. Comp: $275.36kMs. Elisa Michael Luqman Esq. (Age 59)J.D., M.B.A., Chief Legal Officer (SEC) & Board Sec. Comp: $251.33kMs. Denise PufalDirector of OperationsMs. LaChoenda RosalesDirector of AccountingLaTanya BrackensDirector of ComplianceMs. Vivian Sanders M.B.A.Director of MarketingMore ExecutivesKey CompetitorsAugmedixNASDAQ:AUGXTabula Rasa HealthCareNASDAQ:TRHCAmerican WellNYSE:AMWLPuma BiotechnologyNASDAQ:PBYITScan TherapeuticsNASDAQ:TCRXView All CompetitorsInsiders & InstitutionsBarclays PLCSold 63,449 shares on 9/21/2023Ownership: 0.010%California State Teachers Retirement SystemSold 64,018 shares on 8/21/2023Ownership: 0.048%Goldman Sachs Group Inc.Bought 797,096 shares on 8/15/2023Ownership: 0.136%Y Intercept Hong Kong LtdBought 288,347 shares on 8/15/2023Ownership: 0.044%Point72 Asset Management L.P.Bought 195,012 shares on 8/15/2023Ownership: 0.032%View All Insider TransactionsView All Institutional Transactions NUTX Stock - Frequently Asked Questions Should I buy or sell Nutex Health stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NUTX shares. View NUTX analyst ratings or view top-rated stocks. What is Nutex Health's stock price forecast for 2023? 2 equities research analysts have issued 12-month price objectives for Nutex Health's stock. Their NUTX share price forecasts range from $2.50 to $3.00. On average, they expect the company's stock price to reach $2.75 in the next twelve months. This suggests a possible upside of 1,226.6% from the stock's current price. View analysts price targets for NUTX or view top-rated stocks among Wall Street analysts. How have NUTX shares performed in 2023? Nutex Health's stock was trading at $1.90 at the beginning of the year. Since then, NUTX stock has decreased by 89.1% and is now trading at $0.2073. View the best growth stocks for 2023 here. Are investors shorting Nutex Health? Nutex Health saw a increase in short interest in September. As of September 15th, there was short interest totaling 2,440,000 shares, an increase of 114.0% from the August 31st total of 1,140,000 shares. Based on an average trading volume of 2,060,000 shares, the short-interest ratio is currently 1.2 days. Approximately 0.7% of the company's stock are sold short. View Nutex Health's Short Interest. When is Nutex Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 20th 2023. View our NUTX earnings forecast. How were Nutex Health's earnings last quarter? Nutex Health Inc. (NASDAQ:NUTX) posted its quarterly earnings results on Wednesday, August, 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The firm had revenue of $58.92 million for the quarter, compared to analysts' expectations of $62.25 million. Nutex Health had a negative net margin of 225.91% and a negative trailing twelve-month return on equity of 31.81%. What is Nutex Health's stock symbol? Nutex Health trades on the NASDAQ under the ticker symbol "NUTX." How do I buy shares of Nutex Health? Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Nutex Health's stock price today? One share of NUTX stock can currently be purchased for approximately $0.21. How much money does Nutex Health make? Nutex Health (NASDAQ:NUTX) has a market capitalization of $137.21 million and generates $219.29 million in revenue each year. The company earns $-424,780,000.00 in net income (profit) each year or ($0.69) on an earnings per share basis. How many employees does Nutex Health have? The company employs 1,150 workers across the globe. How can I contact Nutex Health? Nutex Health's mailing address is 2455 EAST SUNRISE BLVD. SUITE 1204, FORT LAUDERDALE FL, 33304. The official website for the company is www.nutexhealth.com. The company can be reached via phone at (713) 660-0557, via email at investors@nutexhealth.com, or via fax at 631-670-6780. This page (NASDAQ:NUTX) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.